NCT05431127View on ClinicalTrials.gov

High Dose Inspiratory Muscle Training in LOPD

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

July 19, 2022

Primary Completion Date

January 1, 2025

Study Completion Date

January 1, 2025

Conditions
Late-Onset Pompe DiseaseLysosomal Disease
Interventions
DEVICE

IMT therapy using the Pr02 mobile device

Inspiratory Muscle Training using a device used to measure and increase respiratory strength and performance through resisted breathing exercises.

Trial Locations (1)

27705

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

Genzyme, a Sanofi Company

INDUSTRY

lead

Duke University

OTHER